Redeye is making some downward adjustments to our estimates and valuation, following the Q3 report a...
* Q3: -3% org. sales growth, 0% adj. EBITA growth, weak cash flow '25e-'27e adj.
Organic growth returned in Q3 y/y after some challenging years, but net sales and EBIT were slightly...
Redeye has updated its estimates and valuation for Sleep Cycle following the Q3 2025 report, which s...
Redeye retains its positive view of CombinedX following a solid Q3, showing increasing margins due t...
Redeye takes a slightly more positive view of Hexatronic following the Q3 report, showing stronger m...
* External headwinds delay earnings recovery until 2026e * '25e-'27e EBIT down 27-3%; 18% EBIT CAGR ...
* Q3 EBITDA of NOK 14m * Signs of improvement * Limited underlying estimate changes - DCF NOK 15/sh ...
* '25e-'27e adj. EBITA down 6-4% * '26e-'27e: expect better margins but less org.
* Stronger than expected across the board * We raise '25e-'27e adj.
Fable Media has initiated a written procedure to refinance its outstanding bond maturing in 2025.
* Sales beat, lower costs and executing on M&A * Adj.
Redeye notes that Enea's Q3 report came in below expectations, showing lacklustre growth while margi...
Volumes were down and utilisation ratios weaker than year ago in Q3, like the company had anticipate...
Consti's Q3 results were fairly in line with our expectations Net sales in Q3 amounted to EUR 90.
